Centrus Energy Corp. is a critical supplier to the global nuclear power industry, providing essential fuel components like Low-Enriched Uranium (LEU) and conversion services to utilities worldwide, alongside specialized engineering expertise through its Technical Solutions segment. Operating within the Energy sector's Uranium industry, Centrus plays a pivotal role in the nuclear fuel supply chain. The company's recent performance shows a mixed trend, with Q4 2025 EPS of $0.79 missing the estimate of $1.42, following a Q3 2025 EPS of $0.19 which also missed the estimate of $0.35679. However, the preceding quarters saw stronger results, with Q2 2025 EPS at $1.59 beating the estimate of $0.57555 and Q1 2025 EPS at $1.0606 significantly exceeding the estimate of -$0.0775. Revenue figures are available for Q4 2025 ($146.2 million actual vs. $147.8 million estimate) and Q3 2025 ($74.9 million actual, estimate not provided), indicating revenue performance that has been closer to estimates in the most recent reported quarter. Historically, Centrus has demonstrated an ability to beat analyst estimates, particularly in earlier quarters like Q1 2025, but has faced challenges in meeting expectations in the most recent periods, specifically Q3 and Q4 2025. The company's revenue growth trajectory has been variable, with significant fluctuations between quarters. Recent news highlights Centrus's strategic expansion plans, including a $560 million investment in its Oak Ridge uranium enrichment centrifuge manufacturing plant to achieve high-rate production by 2029, and a substantial $900 million HALEU contract from the U.S. Department of Energy. These developments position Centrus as a key player in reducing Western reliance on Russian nuclear fuel and supporting advanced reactor development, especially with the U.S. ban on Russian uranium imports. Investors will be watching for continued progress on the Oak Ridge expansion and the Ohio facility build-out, as well as any further government contracts or international agreements that could solidify Centrus's market position and its ability to scale production to meet its substantial order backlog. The ongoing strength in spot uranium prices and the broader market dynamics surrounding nuclear energy policy will also be key indicators.